In Colombia, a bill that would introduce the vaccine into Bogotá’s public health care system has just failed for the third time.
German virologist Harold zur Hausen’s Nobel Prize is a reminder that there is overwhelming scientific consensus that HPV is the cause of cervical cancer.
A majority of Colombian women get Pap smears, but new studies show that ten percent of such tests administered in Colombia yield inaccurate results.
The LA Times calls HHS proposal a ‘sneak attack on family planning’; HPV vaccine banned from Catholic school in UK; HIV rates among drug users worldwide rises; Wall Street takes welfare it begrudges to women; Why the election matters for reproductive rights; Jesuit priest embraces social support programs to reduce abortion; Remote control male birth control.
Pro-choicers are voting on values of our own — values of liberty, health, and scientific knowledge.
New Citizenship and Immigration Services regulations requiring HPV vaccination for young immigrant women seeking adjustment of status only erects further barriers in an already onerous immigration process.
The women’s health community’s own debate about the HPV The women’s health community’s own debate about the HPV vaccine has long been overshadowed by Merck’s aggressive marketing and lobbying efforts. In the midst of new critiques of Gardasil, now is a good time for women’s health advocates to reflect on what has happened, examine what remains unknown and recommit to providing the best in education and prevention.
Should personal belief be protected at the workplace?; Sen. Joe Biden never refused communion on basis of his support for abortion rights; One year after legalization Mexico City struggles to provide open access to abortion care; Study finds ideas about sex do not affect HPV vaccine use; ‘Extended cycle’ contraception garnering interest.
In what seems to be more like tabloid style reportage than journalism one might expect from CNN, a report on Gardasil uses fear-mongering to tell a story of half-truths and incomplete facts.
A teen’s sexual activity doesn’t predict her future risk for HPV, and shouldn’t determine whether she receives the HPV vaccine, University of Michigan researchers find.